miconazole has been researched along with Bacterial Disease in 17 studies
Miconazole: An imidazole antifungal agent that is used topically and by intravenous infusion.
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 2,4-dichlorobenzyl group.
miconazole : A racemate composed of equimolar amounts of (R)- and (S)-miconazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. It inhibits the synthesis of ergosterol, a critical component of fungal cell membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients treated with cytotoxic therapy expected to produce neutropenia lasting two or more weeks were randomly assigned in a double-blind study to receive intravenous miconazole or placebo concomitant with empiric antibiotics to test whether miconazole can prevent fungal sepsis." | 9.06 | Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. ( Braine, HG; Merz, WG; Saral, R; Vaughan, WP; Wingard, JR, 1987) |
| "Patients treated with cytotoxic therapy expected to produce neutropenia lasting two or more weeks were randomly assigned in a double-blind study to receive intravenous miconazole or placebo concomitant with empiric antibiotics to test whether miconazole can prevent fungal sepsis." | 5.06 | Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole. ( Braine, HG; Merz, WG; Saral, R; Vaughan, WP; Wingard, JR, 1987) |
| "Hospital-acquired and community-acquired bacterial infections have already put a heavy burden on the global health system." | 2.61 | Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids. ( Zhang, B, 2019) |
| "The different forms of hospital infections have been reviewed and classified as 1." | 1.26 | [Infections in children with malignant disease (author's transl)]. ( Krepler, P, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (58.82) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Hatnapure, GD | 1 |
| Keche, AP | 1 |
| Rodge, AH | 1 |
| Birajdar, SS | 1 |
| Tale, RH | 1 |
| Kamble, VM | 1 |
| Ratnakar Reddy, K | 1 |
| Poornachandra, Y | 2 |
| Jitender Dev, G | 1 |
| Mallareddy, G | 1 |
| Nanubolu, JB | 1 |
| Kumar, CG | 2 |
| Narsaiah, B | 1 |
| Venepally, V | 1 |
| Prasad, RBN | 1 |
| Jala, RCR | 1 |
| Zhang, B | 1 |
| Ngoc Toan, V | 1 |
| Dinh Thanh, N | 1 |
| Minh Tri, N | 1 |
| Thi Thu Huong, N | 1 |
| Schierholz, JM | 1 |
| Nagelschmidt, K | 1 |
| Nagelschmidt, M | 1 |
| Lefering, R | 2 |
| Yücel, N | 2 |
| Beuth, J | 2 |
| Maegele, M | 1 |
| Max, M | 1 |
| Rossaint, R | 1 |
| Koch, A | 1 |
| Schwarz, R | 1 |
| Korenkov, M | 1 |
| Bach, A | 1 |
| Schierholz, J | 1 |
| Pulverer, G | 1 |
| Neugebauer, EA | 1 |
| Maksymiuk, AW | 1 |
| Thongprasert, S | 1 |
| Hopfer, R | 1 |
| Luna, M | 1 |
| Fainstein, V | 1 |
| Bodey, GP | 2 |
| Rosenbaum, B | 1 |
| Valdivieso, M | 1 |
| Bolivar, R | 1 |
| Van Cutsem, J | 1 |
| Van Gerven, F | 1 |
| De Keyser, H | 1 |
| White, I | 1 |
| Blatchford, N | 1 |
| Nisselle, P | 1 |
| Zazgornik, J | 1 |
| Schmidt, P | 1 |
| Kopsa, H | 1 |
| Pils, P | 1 |
| Balcke, P | 1 |
| Krepler, P | 1 |
| Landers, DV | 1 |
| Wingard, JR | 1 |
| Vaughan, WP | 1 |
| Braine, HG | 1 |
| Merz, WG | 1 |
| Saral, R | 1 |
| Blanc, B | 1 |
2 reviews available for miconazole and Bacterial Disease
| Article | Year |
|---|---|
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Mic | 2019 |
The treatment of vaginitis: Trichomonas, yeast, and bacterial vaginosis.
Topics: Antifungal Agents; Bacterial Infections; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administratio | 1988 |
3 trials available for miconazole and Bacterial Disease
| Article | Year |
|---|---|
Antimicrobial central venous catheters in oncology: efficacy of a rifampicin-miconazole-releasing catheter.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antifungal Agents; Bacteria | 2010 |
Reduced colonization and infection with miconazole-rifampicin modified central venous catheters: a randomized controlled clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Catheteriza | 2004 |
Prevention of fungal sepsis in patients with prolonged neutropenia: a randomized, double-blind, placebo-controlled trial of intravenous miconazole.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amphotericin B; Bacterial Infections; Bone Marrow Transpla | 1987 |
12 other studies available for miconazole and Bacterial Disease
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel piperazine derivatives of flavone as potent anti-inflammatory and antimicrobial agent.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Bacteria; Bacterial Infections; Flavones; Fungi; Hu | 2012 |
Synthesis of novel amide functionalized 2H-chromene derivatives by Ritter amidation of primary alcohol using HBF4·OEt2 as a mild and versatile reagent and evaluation of their antimicrobial and anti-biofilm activities.
Topics: Amides; Anti-Infective Agents; Bacteria; Bacterial Infections; Benzopyrans; Biofilms; Borates; Boric | 2015 |
Synthesis of novel ethyl 1-ethyl-6-fluoro-7-(fatty amido)-1,4-dihydro-4-oxoquinoline-3-carboxylate derivatives and their biological evaluation.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Antioxidants; Bac | 2016 |
Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having d-glucose moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Cou | 2020 |
Systemic candidiasis in cancer patients.
Topics: Acute Disease; Amphotericin B; Bacterial Infections; Bacteriological Techniques; Candida; Candidiasi | 1984 |
Effect of systemic antimicrobial prophylaxis on microbial flora.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Carcinoma | 1982 |
Sensitivity of Moraxella bovis in vitro to miconazole nitrate.
Topics: Animals; Bacterial Infections; Cattle; Cattle Diseases; Drug Resistance, Microbial; Imidazoles; Kera | 1983 |
The treatment of secondary bacterial infections in atopic eczema with miconazole plus hydrocortisone.
Topics: Administration, Topical; Anti-Inflammatory Agents; Bacterial Infections; Dermatitis, Atopic; Drug Co | 1983 |
The management of vaginal discharges.
Topics: Bacterial Infections; Candidiasis, Vulvovaginal; Female; Humans; Metronidazole; Miconazole; Nystatin | 1980 |
[Mixed infection after renal transplantation (author's transl)].
Topics: Bacterial Infections; Female; Gentamicins; Humans; Immunosuppression Therapy; Kidney Transplantation | 1979 |
[Infections in children with malignant disease (author's transl)].
Topics: Amphotericin B; Antineoplastic Agents; Bacterial Infections; Blood Transfusion; Child; Communicable | 1979 |
[Effectiveness of 400 mg miconazole pellets in various types of vaginitis].
Topics: Administration, Topical; Adult; Bacterial Infections; Candidiasis, Vulvovaginal; Capsules; Female; H | 1985 |